Search

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen receptor T cell therapy, lymphoma, leukemia, multiple myeloma, and nonmalignant blood disorders.

… Tuesday, December 10, 2019 The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen

The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.

… Tuesday, August 15, 2023 Chi Nguyen , a PhD student attending the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , has been awarded the 2023 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale.

… Wednesday, May 13, 2020 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) revealed the effects of Medicaid expansion on cancer death rates on a national scale. The landmark study found that states that adopted Medicaid expansion following the passage of the Affordable Care Act

People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.

… Tuesday, July 13, 2021 When it comes to body fat, what type you have and where it’s located is just as important as how much you have. Some people who are technically overweight are perfectly healthy because of where their fat is stored — subcutaneously (under the skin) rather than viscerally (around

A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.

… Friday, October 4, 2019 Summary Researchers discovered that blocking a pathway called CHRM4 increases the production of red blood cells. Anemia , a condition in which there are not enough red blood cells to transport oxygen throughout the body, affects millions in the United States every year. It can

… Wednesday, March 30, 2022 Andrew McMahon, front man of the bands Something Corporate and Jack’s Mannequin, was a rock star on the rise when he was suddenly diagnosed with lymphoblastic leukemia at 22 years old. How did he handle this life-changing challenge? And how did his relationship survive the stress

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.

… Thursday, December 21, 2023 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2023. Laboratory research teams across the institution investigated many fundamental biological questions to advance the global understanding of cancer and the development

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution as President and Chief Executive Officer.

… Monday, September 19, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS , an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.

… Friday, October 1, 2010 Summary As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials. As part of a commitment

An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.

… Tuesday, December 10, 2024 Summary With more people surviving longer after lung cancer , close management of those who have had successful treatment is more important than ever. MSK’s Lung Cancer Survivorship Program provides regular screening for recurrent cancers or new tumors, as well as guidance